Short-Acting GHRH Analog (Mod GRF 1-29)

CJC-1295 (no DAC) (10mg) will be supplied in Australia by Daza Enhanced with fast domestic shipping to all states and territories.

CJC-1295 without DAC — also called Mod GRF 1-29 — is a non-DAC modified GHRH analog with a ~30 minute biological half-life. The short activity window produces a defined, pulsatile GH release that mimics endogenous GH secretion patterns — distinct from the sustained-release profile of the DAC-modified version.

CJC-1295 (no DAC) is most often studied alongside Ipamorelin: the two compounds activate complementary receptors (GHRH-receptor and ghrelin-receptor respectively), producing a synergistic GH pulse that exceeds either peptide alone.

Key Research Areas

• Pulsatile GH Release — Short, sharp GH pulse mimicking endogenous secretion rhythm
• Dual-Pathway Research — Studied with Ipamorelin (GHRH + ghrelin receptor activation) for synergistic GH pulse
• Body Composition — Downstream IGF-1 elevation studied for protein synthesis and fat oxidation
• Tissue Repair — GH/IGF-1 axis studied across muscle and connective tissue models
• Sleep Research — Studied around nocturnal GH secretion for sleep-architecture research

Supplied as lyophilized powder at ≥99% purity, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.